152
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis of Novel N,N-Disubstituted Ethyl P-[2-(1H-Indol-3-YL)Acetyl]Phosphoramidates and Their Biological Activity

, , , , &
Pages 2013-2022 | Received 09 Mar 2015, Accepted 26 Apr 2015, Published online: 02 Dec 2015
 

GRAPHICAL ABSTRACT

Abstract

A series of novel N,N-disubstituted ethyl P-[2-(1H-indol-3-yl)acetyl]phosphoramid-ates were synthesized. All title compounds were characterized by IR, NMR (1H, 13C, 31P) spectra, mass spectra, and C, H, N analysis. The anticancer activity of the title compounds was evaluated in two human cell lines MCF-7 (breast cancer) and HeLa (Cervical cancer) cell lines by the use of the MTT assay, and the IC50 values were determined. The derivatives with substituted piperazines exhibited significant cytotoxicity against the tested cell lines at 5 μM and displayed low IC50 values in the region of 5.8–8.8 μM for MCF-7 cell lines and 14.8–16.4 μM for HeLa cell lines when compared with the standard doxorubicin (5.4 and 14.2 μM).

ACKNOWLEDGMENTS

The authors acknowledge with gratitude the help of Aptus Bio-Sciences Private Limited, Mahabubnagar 509002, Andhra Pradesh, India and Hyderabad Central University, India for providing anticancer activity and spectral data, respectively.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 61.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 2,235.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.